Dynavax Technologies
Utility Patent Applications

Last updated:

List of all Dynavax Technologies patents 7 in total

Status Patent
Application
Utility: ALKYL CHAIN MODIFIED IMIDAZOQUINOLINE TLR7/8 AGONIST COMPOUNDS AND USES THEREOF External link
Filling date: 8 Sep 2025 Issue date: 3 Feb 2022
Application
Utility: IMMUNOGENIC COMPOSITION AGAINST SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-CoV-2) External link
Filling date: 8 Sep 2025 Issue date: 7 Oct 2021
Application
Utility: COMBINATION OF A PD-1 ANTAGONIST AND CPG-C TYPE OLIGONUCLEOTIDE FOR TREATING CANCER External link
Filling date: 8 Sep 2025 Issue date: 1 Jul 2021
Application
Utility: ALKYL CHAIN MODIFIED IMIDAZOQUINOLINE TLR7/8 AGONIST COMPOUNDS AND USES THEREOF External link
Filling date: 8 Sep 2025 Issue date: 25 Jun 2020
Application
Utility: TOLL-LIKE RECEPTOR ANTAGONIST COMPOUNDS AND METHODS OF USE External link
Filling date: 8 Sep 2025 Issue date: 14 Nov 2019
Application
Utility: IMMUNOSTIMULATORY SEQUENCE OLIGONUCLEOTIDES AND METHODS OF USING THE SAME External link
Filling date: 8 Sep 2025 Issue date: 12 Sep 2019
Application
Utility: BRANCHED CHIMERIC COMPOUNDS, AND METHODS OF USE THEREOF External link
Filling date: 8 Sep 2025 Issue date: 8 Aug 2019

Showing 1 to 7 of 7 patents.